Among pregnant women with IBD, no significant difference was demonstrated in the GMC (95% CI) anti-S levels in accordance with anti-TNF treatment (2408 (718–8071) in anti-TNF treated women vs. 2457 (1419–4253) in women not treated with anti TNF). The gene discussed is TNF; the disease is inflammatory bowel disease.